Jia Song

856 total citations · 1 hit paper
27 papers, 631 citations indexed

About

Jia Song is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Jia Song has authored 27 papers receiving a total of 631 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 10 papers in Surgery. Recurrent topics in Jia Song's work include Cancer Immunotherapy and Biomarkers (7 papers), Pancreatic and Hepatic Oncology Research (6 papers) and Helicobacter pylori-related gastroenterology studies (4 papers). Jia Song is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), Pancreatic and Hepatic Oncology Research (6 papers) and Helicobacter pylori-related gastroenterology studies (4 papers). Jia Song collaborates with scholars based in China, United States and Senegal. Jia Song's co-authors include Shangli Cai, Shiqing Chen, Xiaochen Zhao, Yuzi Zhang, Zhijie Wang, Yuezong Bai, Longgang Cui, Qīng Wáng, Zhengyi Zhao and Chuang Qi and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Science Advances.

In The Last Decade

Jia Song

24 papers receiving 624 citations

Hit Papers

Use of Immunotherapy With Programmed Cell Death 1 vs Prog... 2019 2026 2021 2023 2019 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jia Song China 12 387 220 133 120 113 27 631
Junxun Ma China 18 596 1.5× 373 1.7× 95 0.7× 135 1.1× 124 1.1× 45 796
Carla M. van Herpen Netherlands 14 325 0.8× 146 0.7× 98 0.7× 113 0.9× 195 1.7× 27 608
Piotr Wysocki Poland 10 310 0.8× 121 0.6× 91 0.7× 120 1.0× 189 1.7× 20 548
Xiaowei Dang China 12 224 0.6× 165 0.8× 92 0.7× 82 0.7× 163 1.4× 33 509
Vito Longo Italy 12 284 0.7× 128 0.6× 65 0.5× 95 0.8× 127 1.1× 29 487
Yibing Peng United States 14 352 0.9× 99 0.5× 151 1.1× 236 2.0× 153 1.4× 24 642
Sojun Hoshimoto Japan 16 493 1.3× 215 1.0× 289 2.2× 78 0.7× 166 1.5× 48 775
Yasuto Yoneshima Japan 17 669 1.7× 482 2.2× 62 0.5× 101 0.8× 177 1.6× 54 944
Eric R. Manusama Netherlands 12 266 0.7× 153 0.7× 88 0.7× 81 0.7× 162 1.4× 14 546
Gerry Gin Wai Kwok China 7 343 0.9× 109 0.5× 60 0.5× 131 1.1× 79 0.7× 10 518

Countries citing papers authored by Jia Song

Since Specialization
Citations

This map shows the geographic impact of Jia Song's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jia Song with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jia Song more than expected).

Fields of papers citing papers by Jia Song

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jia Song. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jia Song. The network helps show where Jia Song may publish in the future.

Co-authorship network of co-authors of Jia Song

This figure shows the co-authorship network connecting the top 25 collaborators of Jia Song. A scholar is included among the top collaborators of Jia Song based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jia Song. Jia Song is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Song, Jia, Teng Yang, Luhao Liu, et al.. (2025). Current status and influencing factors of motor-cognitive risk syndrome in the older rural Chinese population: a cross-sectional study. Frontiers in Public Health. 13. 1604019–1604019.
3.
Song, Jia, Liming Wang, Xinghong Guo, et al.. (2024). Mesenchymal stromal cells ameliorate mitochondrial dysfunction in α cells and hyperglucagonemia in type 2 diabetes via SIRT1/FoxO3a signaling. Stem Cells Translational Medicine. 13(8). 776–790.
4.
Yang, Mengmeng, Longqing Xia, Jia Song, et al.. (2023). Puerarin ameliorates metabolic dysfunction-associated fatty liver disease by inhibiting ferroptosis and inflammation. Lipids in Health and Disease. 22(1). 202–202. 36 indexed citations
5.
Zhang, Lei, et al.. (2021). An extremely atypical presentation of esophageal squamous cell carcinoma with pancreatic and hepatic metastases. Medicine. 100(20). e25785–e25785. 1 indexed citations
6.
Chen, Yinglei, et al.. (2021). Investigating SARS-CoV-2 persistent contamination in different indoor environments. Environmental Research. 202. 111763–111763. 25 indexed citations
7.
Long, Guoxian, Lin Yang, Jing Zhao, et al.. (2021). The clinical prognostic value of PD-L1 after concurrent chemoradiotherapy in Chinese nasopharyngeal carcinoma patients. Annals of Translational Medicine. 9(22). 1650–1650. 4 indexed citations
8.
Chen, Hongmei, Xiuxiu Cong, Chenxi Wu, et al.. (2020). Intratumoral delivery of CCL25 enhances immunotherapy against triple-negative breast cancer by recruiting CCR9 + T cells. Science Advances. 6(5). eaax4690–eaax4690. 70 indexed citations
9.
Wang, Longrong, Kai Yan, Xigan He, et al.. (2020). LRP1B or TP53 mutations are associated with higher tumor mutational burden and worse survival in hepatocellular carcinoma. Journal of Cancer. 12(1). 217–223. 36 indexed citations
10.
Ma, Junxun, Danyang Sun, Jinliang Wang, et al.. (2020). Immune checkpoint inhibitors combined with chemotherapy for the treatment of advanced pancreatic cancer patients. Cancer Immunology Immunotherapy. 69(3). 365–372. 23 indexed citations
11.
Sun, Danyang, Junxun Ma, Jinliang Wang, et al.. (2019). Anti-PD-1 therapy combined with chemotherapy in patients with advanced biliary tract cancer. Cancer Immunology Immunotherapy. 68(9). 1527–1535. 39 indexed citations
12.
Duan, Jianchun, Longgang Cui, Xiaochen Zhao, et al.. (2019). Use of Immunotherapy With Programmed Cell Death 1 vs Programmed Cell Death Ligand 1 Inhibitors in Patients With Cancer. JAMA Oncology. 6(3). 375–375. 249 indexed citations breakdown →
13.
Gao, Yan, et al.. (2018). Clinical benefit from afatinib in an advanced squamous cell lung carcinoma patient harboring <em>HER2</em> S310Y mutation: a case report. OncoTargets and Therapy. Volume 11. 8705–8710. 5 indexed citations
15.
Liu, Pan, Jia Song, He Liu, et al.. (2018). Insulin regulates glucagon-like peptide-1 secretion by pancreatic alpha cells. Endocrine. 62(2). 394–403. 11 indexed citations
16.
Wang, Jun, Xufeng Guo, Shijie Yu, et al.. (2014). MDR1 C3435T polymorphism and inflammatory bowel disease risk: a meta-analysis. Molecular Biology Reports. 41(4). 2679–2685. 10 indexed citations
17.
Cao, Zhuo, Jia Song, Jun Wang, et al.. (2014). Association between Polymorphisms in XRCC1 Gene and Treatment Outcomes of Patients with Advanced Gastric Cancer: A Systematic Review and Meta-Analysis. PLoS ONE. 9(1). e85357–e85357. 10 indexed citations
18.
Wang, Jun, Xufeng Guo, Jixiang Zhang, et al.. (2014). Thymidylate synthase genetic polymorphisms and colorectal cancer risk: A meta-analysis. Clinics and Research in Hepatology and Gastroenterology. 38(4). 481–490. 3 indexed citations
19.
Wang, Jun, Xufeng Guo, Shijie Yu, et al.. (2014). Association between CD14 Gene Polymorphisms and Cancer Risk: A Meta-Analysis. PLoS ONE. 9(6). e100122–e100122. 14 indexed citations
20.
Wang, Jun, Xufeng Guo, Shijie Yu, et al.. (2014). Efficacy and Safety of Proton Pump Inhibitors (PPIs) Plus Rebamipide for Endoscopic Submucosal Dissection-induced Ulcers: A Meta-analysis. Internal Medicine. 53(12). 1243–1248. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026